Our activity

The Association of Innovative Pharmaceutical Manufacturers founded in 1992 consists of 26 research and development oriented pharmaceutical companies in Hungary, which account for more than 50% of the domestic medicine turnover.  

Our member companies do ground-breaking work in improving general health and quality of life via the invention and development of novel innovative medicines that present a breakthrough in the treatment of diseases that cannot be treated at all or not with the proper efficacy.

 

We have a common goal: The Hungarian population should be able to have a broad and quick  access to the latest medical solutions based on modern discoveries. 

 

To this end, we continuously cooperate 

  • with Hungarian government organisations, 
  • health authorities, 
  • patient organisations, social organisations,  
  • educational institutions, 

and help to achieve our common goals through regular professional recommendations, analyses and the implementation of various professional projects.

Board

Dr. Ákos Kókai-Nagy

Biogen Hungary general manager

Chairman of the Board

Selen Zeydanli BISSON

Merck Kft. Managing Director

AIPM Board member

Raffaella Claudia BONDI

General Manager, Roche Kft.

AIPM Board member

Dr. Dalma Sugár

Managing Director, AbbVie Ltd.

AIPM Board Member

Dr. Péter VERECKEI

Pfizer General Manager

AIPM Board Member

Paul HUGGINS

Novo Nordisk general manager

AIPM Board Member

Our team

KATALIN SZALÓKI, PhD

Director

Veronika, Kovács-Borbás

Market Access Manager

KOCSIS, Janka PharmD

Alliance Manager

Kinga SHALABY

Office Manager

Kata Kárándi

Event Coordinator & Project Manager

International Relations

The Association of Innovative Pharmaceutical Manufacturers is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). In Brussels the EFPIA represents around 2000 companies committed to researching, developing and bringing to patients new medicines that will improve health and quality of life. The AIPM proudly and actively represents Hungarian interests on the European scene as well, and brings European industry initiatives to Hungary directly.  


For more information, please visit the EFPIA website: https://www.efpia.eu/

Our activity

The Association of Innovative Pharmaceutical Manufacturers founded in 1992 consists of 26 research and development oriented pharmaceutical companies in Hungary, which account for more than 50% of the domestic medicine turnover.  

Our member companies do ground-breaking work in improving general health and quality of life via the invention and development of novel innovative medicines that present a breakthrough in the treatment of diseases that cannot be treated at all or not with the proper efficacy.

 

We have a common goal: The Hungarian population should be able to have a broad and quick  access to the latest medical solutions based on modern discoveries. 

 

To this end, we continuously cooperate 

  • with Hungarian government organisations, 
  • health authorities, 
  • patient organisations, social organisations,  
  • educational institutions, 

and help to achieve our common goals through regular professional recommendations, analyses and the implementation of various professional projects. 

Board

Dr. Kókai-Nagy Ákos

Biogen Hungary general manager

Chairman of the Board

Selen Zeydanli BISSON

Merck Kft. Managing Director

AIPM Board Member

Raffaella Claudia BONDI

General Manager, Roche Kft.

AIPM Board member

Dalma, SUGÁR MD

Managing Director, AbbVie Ltd.

AIPM Board Member

Dr. Péter VERECKEI

Pfizer General Manager

AIPM Board Member

Paul HUGGINS

Novo Nordisk general manager

AIPM Board Member

Member Companies

Our Team

katalin szalóki, PhD

Director

Veronika, Kovács-Borbás

Market Access Manager

KOCSIS, Janka PharmD

Alliance manager

Kinga SHALABY

Office Manager

Kata Kárándi

Event Coordinator & Project Manager

International Relations

The Association of Innovative Pharmaceutical Manufacturers is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). In Brussels the EFPIA represents around 2000 companies committed to researching, developing and bringing to patients new medicines that will improve health and quality of life. The AIPM proudly and actively represents Hungarian interests on the European scene as well, and brings European industry initiatives to Hungary directly.  


For more information, please visit the EFPIA website: https://www.efpia.eu/